Rechargeable magnesium batteries (RMB) have been regarded as an alternative to lithium‐based batteries because of their abundant elemental resource, high theoretical volumetric capacity, and multi‐electron redox reaction without the dendrite formation of magnesium metal anode. However, their development is impeded by their poor electrode/electrolyte compatibility and the strong Coulombic effect of the multivalent Mg2+ ions in cathode materials. Herein, copper sulfide material is developed as a high‐energy cathode for RMBs with a non‐corrosive Mg‐ion electrolyte. Given the benefit of its optimized interlayer structure, good compatibility with the electrolyte, and enhanced surface area, the as‐prepared copper sulfide cathode exhibits unprecedented electrochemical Mg‐ion storage properties, with the highest specific capacity of 477 mAh g−1 and gravimetric energy density of 415 Wh kg−1 at 50 mA g−1, among the reported cathode materials of metal oxides, metal chalcogenides, and polyanion‐type compounds for RMBs. Notably, an impressive long‐term cycling performance with a stable capacity of 111 mAh g−1 at 1 C (560 mA g−1) is achieved over 1000 cycles. The results of the present study offer an avenue for designing high‐performance cathode materials for RMBs and other multivalent batteries.
As an innovative additive manufacturing
process, 4D printing can
be utilized to generate predesigned, self-assembly structures which
can actuate time-dependent, and dynamic shape-changes. Compared to
other manufacturing techniques used for tissue engineering purposes,
4D printing has the advantage of being able to fabricate reprogrammable
dynamic tissue constructs that can promote uniform cellular growth
and distribution. For this study, a digital light processing (DLP)-based
printing technique was developed to fabricate 4D near-infrared (NIR)
light-sensitive cardiac constructs with highly aligned microstructure
and adjustable curvature. As the curvature of the heart is varied
across its surface, the 4D cardiac constructs can change their shape
on-demand to mimic and recreate the curved topology of myocardial
tissue for seamless integration. To mimic the aligned structure of
the human myocardium and to achieve the 4D shape change, a NIR light-sensitive
4D ink material, consisting of a shape memory polymer and graphene,
was created to fabricate microgroove arrays with different widths.
The results of our study illustrate that our innovative NIR-responsive
4D constructs exhibit the capacity to actuate a dynamic and remotely
controllable spatiotemporal transformation. Furthermore, the optimal
microgroove width was discovered via culturing human induced pluripotent
stem cell-derived cardiomyocytes and mesenchymal stem cells onto the
constructs’ surface and analyzing both their cellular morphology
and alignment. The cell proliferation profiles and differentiation
of tricultured human-induced pluripotent stem cell-derived cardiomyocytes,
mesenchymal stem cells, and endothelial cells, on the printed constructs,
were also studied using a Cell Counting Kit-8 and immunostaining.
Our results demonstrate a uniform distribution of aligned cells and
excellent myocardial maturation on our 4D curved cardiac constructs.
This study not only provides an efficient method for manufacturing
curved tissue architectures with uniform cell distributions, but also
extends the potential applications of 4D printing for tissue regeneration.
Objectives: We aimed to (1) assess parental hesitancy about category A (Expanded Program on Immunization (EPI)) and B (non-EPI) vaccines, (2) assess parental willingness for COVID-19 and influenza vaccinations, and (3) explore the association of vaccination hesitancy of parents and healthcare workers (HCWs). Methods: The study was performed in Wuxi, eastern China between 21 September 2020 and 17 October 2020. Parents of children aged <18 years and HCWs were recruited from the selected immunization clinics. Vaccine hesitancy was assessed using the Strategic Advisory Group of Experts (SAGE) vaccine hesitancy survey (VHS) by summing the total score for 10 items (maximum 50 points). Results: A total of 3009 parents and 86 HCWs were included in the analysis. The category A VHS scores were significantly higher than the category B VHS scores (p = 0.000). Overall, 59.3% and 52.4% of parents reported willingness to avail COVID-19 and influenza vaccination for their children, respectively; 51.2% of the HCWs wanted to be vaccinated against COVID-19. Parental category B VHS scores were associated with HCW category B VHS scores (r = 0.928, p = 0.008). Conclusions: In China, parents are more hesitant about category B vaccines than category A vaccines. More than 40% of parents showed hesitancy and a refusal to use COVID-19 and influenza vaccines.
Background
The duration of humoral and T and cell response after the infection of SARS-CoV-2 remains unclear.
Methods
We performed a cross-sectional study to assess the virus-specific antibody and memory T and B cell responses in COVID-19 patients up to 343 days after infection. Neutralizing antibodies and antibodies against the receptor-binding domain, spike, and nucleoprotein of SARS-CoV-2 were measured. Virus-specific memory T and B cell responses were analyzed.
Results
We enrolled 59 COVID-19 patients, including 38 moderate, 16 mild, and five asymptomatic patients; 31 (52.5%) were men, and 28 (47.5%) were women. The median age was 41 (interquartile range [IQR]: 30–55). The median day from symptom onset to enrollment was 317 days (range 257 to 343 days). We found that approximately 90% of patients still have detectable IgG antibodies against spike and nucleocapsid proteins and neutralizing antibodies against pseudovirus, whereas ~60% of patients had detectable IgG antibodies against receptor binding domain and surrogate virus-neutralizing antibodies. SARS-CoV-2-specific IgG + memory B cell and IFN-γ secreting T cell responses were detectable in over 70% of patients.
Conclusions
SARS-CoV-2-specific immune memory response persists in most patients nearly one year after infection, which provides a promising sign for prevention from reinfection and vaccination strategy.
Highlights
We collected farmer data from middle (MR), double (DR), and ratoon rice (RR) in China.
We assessed energy balance, carbon footprint, and economic benefit of MR, DR, and RR.
RR achieved higher annual grain yield, net energy yield, and net economic return than MR.
RR is an environment-friendly and economically viable alternative for both MR and DR.
Background: The infectivity and transmission capacity of COVID-2019 cases during the incubation period are not very clear. The manuscript described a cluster to provide information for research on incubation period infection. Methods: We collected the required data from "Public Health Emergency Reporting Management Information System", epidemiological questionnaires for the cases, and laboratories. Results: The cluster involved four generations, each of which was transmitted to the next generation during the incubation period. The time was 2-7 days, 6-7days, 3-8 days and 9 days prior to onset. As of March 11, the fourth-generation cases had no symptoms. Combined with the epidemiological data, we inferred that the source of the cluster was caused by the first-generation, who contacted with more than ten Wuhan people during the annual meeting from January 15 to 16. Two cases in this cluster were tested positive again during isolation and observation after discharge. Conclusions: We determined incubation period was infectious, and confirmed that it was contagious 9 days before the onset. The patients who were discharged might need to be observed for a period of time. This study was useful for the practical work, such as in the investigation of close contacts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.